Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034593
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-04-30
Brief Title:
A Phase 2 Trial of ALIMTA Pemetrexed Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company